Supernus Pharmaceuticals SUPN Business Segments — Marketing expenses

Similar metrics at other companies

BBWIReportable Segment — Marketing Expense

$51M+4.1%

NSAReportable Segment — Marketing expense

$6.34M+14.7%

POWLReportable Segment — Sales and marketing expenses

$8.37M+20.7%

FULTReportable Segment — Marketing

$2.32M+3.7%

ABNBReportable Segment — Marketing

$506M+32.5%

GRNDReportable Segment — Sales and marketing expense

$4.08M+115%

Questions, answered.

What is Supernus Pharmaceuticals's business segments — marketing expenses?

Supernus Pharmaceuticals (SUPN) reported business segments — marketing expenses of $20.7M in Q1 2026.

How has Supernus Pharmaceuticals's business segments — marketing expenses changed year-over-year?

Supernus Pharmaceuticals's business segments — marketing expenses increased by 0.2% year-over-year, from $20.66M to $20.7M.

What is the long-term trend for Supernus Pharmaceuticals's business segments — marketing expenses?

Over 3 years (2022 to 2025), Supernus Pharmaceuticals's business segments — marketing expenses has grown at a -13.1% compound annual growth rate (CAGR), from $120.5M to $78.96M.

What does business segments — marketing expenses mean?

Reflects the investment in advertising, promotional campaigns, and brand awareness initiatives for the segment's product portfolio. This spending is essential for sustaining long-term market position and competitive advantage in the neuroscience space.